Document is current
Any future updates will be listed below
-
Authors
Jonsson, Fredrik https://orcid.org/0000-0002-5259-4731
Schmitt, Christophe https://orcid.org/0000-0001-8001-5584
Petry, Claire
Mercier, Francois https://orcid.org/0000-0002-5685-1408
Frey, Nicolas
Retout, Sylvie https://orcid.org/0000-0003-4867-8438
-
Funding
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd.
- License Information
-
More Information
Article History
Accepted: 19 February 2021
First Online: 12 March 2021
Declarations
:
: This research was sponsored by F. Hoffmann-La Roche Ltd. Open access publication of this article was sponsored by qPharmetra and F. Hoffmann-La Roche Ltd.
: Fredrik Jonsson is an employee of qPharmetra and reports consultancy fees from F. Hoffmann-La Roche Ltd. Christophe Schmitt, Claire Petry, Francois Mercier, Nicolas Frey, and Sylvie Retout are employees and hold stock ownership in F. Hoffmann-La Roche Ltd.
: Not applicable.
: Not applicable.
: Not applicable.
: Qualified researchers may request access to individual patient-level data through the clinical study data request platform (). Further details on Roche’s criteria for eligible studies are available at . For further details on Roche's Global Policy on the Sharing of Clinical Information and how to request access to related clinical study documents, see .
: Not applicable.
: FJ, SR, FM, CP, NF, and CS designed the research. FJ analyzed the data and wrote the manuscript. All authors interpreted the data and contributed to the manuscript.
